We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
2326
DELISTED
Accelerate Diagnostics
AXDX
| $476K | ﹤0.01% |
2,115
+328
| +18% | +$68.5K |
|
2327
Westwood Holdings Group
WHG
$185M
| $476K | ﹤0.01% |
7,891
+1,425
| +22% | +$86.6K |
|
|
NILE
2328
DELISTED
Blue Nile, Inc.
NILE
| $476K | ﹤0.01% |
14,954
+1,700
| +13% | +$53.2K |
|
|
TOWR
2329
DELISTED
Tower International, Inc.
TOWR
| $475K | ﹤0.01% |
17,839
+2,225
| +14% | +$56K |
|
|
CVT
2330
DELISTED
CVENT, INC.
CVT
| $475K | ﹤0.01% |
16,945
+3,100
| +22% | +$85K |
|
|
UNIS
2331
DELISTED
Unilife Corporation
UNIS
| $475K | ﹤0.01% |
11,836
+2,977
| +34% | +$119K |
|
2332
Itaú Unibanco
ITUB
$90.2B
| $471K | ﹤0.01% |
106,292
+10,661
| +11% | +$52K |
|
2333
Rigel Pharmaceuticals
RIGL
$733M
| $471K | ﹤0.01% |
13,185
+670
| +5% | +$18.4K |
|
2334
VSE Corp
VSEC
$6.33B
| $471K | ﹤0.01% |
11,504
+800
| +7% | +$30.5K |
|
|
AT
2335
DELISTED
Atlantic Power Corporation
AT
| $469K | ﹤0.01% |
166,969
+9,200
| +6% | +$25.4K |
|
|
PRAH
2336
DELISTED
PRA Health Sciences, Inc.
PRAH
| $468K | ﹤0.01% |
+16,230
| New | +$453K |
|
|
AXAS
2337
DELISTED
Abraxas Petroleum Corp
AXAS
| $468K | ﹤0.01% |
7,207
+870
| +14% | +$53.9K |
|
|
TXTR
2338
DELISTED
TEXTURA CORPORATION COM
TXTR
| $468K | ﹤0.01% |
17,234
+2,420
| +16% | +$64K |
|
2339
Patrick Industries
PATK
$2.87B
| $467K | ﹤0.01% |
25,309
+3,459
| +16% | +$52.3K |
|
|
ARO
2340
DELISTED
Aeropostale Inc
ARO
| $465K | ﹤0.01% |
133,914
+6,000
| +5% | +$19.2K |
|
2341
Calix
CALX
$2.36B
| $464K | ﹤0.01% |
55,325
+1,400
| +3% | +$12.6K |
|
2342
Cohu
COHU
$2.45B
| $463K | ﹤0.01% |
42,366
+1,850
| +5% | +$20.9K |
|
2343
WPP
WPP
$5.6B
| $463K | ﹤0.01% |
4,066
+66
| +2% | +$7.41K |
|
|
AMCC
2344
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $462K | ﹤0.01% |
90,671
+13,900
| +18% | +$76.4K |
|
2345
Preferred Bank
PFBC
$1.25B
| $460K | ﹤0.01% |
16,748
+900
| +6% | +$24.4K |
|
|
HTB
2346
HomeTrust Bancshares
HTB
$863M
| $460K | ﹤0.01% |
28,820
+1,600
| +6% | +$25.4K |
|
|
GIMO
2347
DELISTED
Gigamon Inc.
GIMO
| $459K | ﹤0.01% |
21,624
+3,625
| +20% | +$70.1K |
|
|
MRD
2348
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $459K | ﹤0.01% |
25,887
-60
| -0.2% | -$1.12K |
|
2349
TC Energy
TRP
$66.6B
| $458K | ﹤0.01% |
10,710
-100
| -0.9% | -$4.46K |
|
2350
Walker & Dunlop
WD
$1.52B
| $458K | ﹤0.01% |
25,808
+500
| +2% | +$8.49K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.